Cabometyx (cabozantinib tablets) — Cigna
Bone cancer (Ewing sarcoma or osteosarcoma)
Initial criteria
- Patient has Ewing sarcoma OR osteosarcoma
- Patient has tried at least one previous systemic regimen (e.g., vincristine, doxorubicin, cyclophosphamide, topotecan, irinotecan, cisplatin, ifosfamide, Stivarga [regorafenib], sorafenib)
Approval duration
1 year